Journals
Publish with us
Publishing partnerships
About us
Blog
Cardiovascular Therapeutics
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Cardiovascular Therapeutics
/
2019
/
Article
/
Fig 1
/
Research Article
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
Figure 1
Overview of patients initiated on sacubitril-valsartan (sac/val).